InvestorsHub Logo

Titan V

04/19/16 11:38 AM

#35118 RE: dr_lowenstein #35063

These are legit concerns investors need to factor in regarding their decision to buy, sell or hold the stock. Personally I think the departures of CMO and CSO carry more weight than the CFO's in OncoSec's case as I think they got a more qualified CFO to replace the old one. Also, my opinion only, departure of key figures in a small company may indicate it could slowly be winding down. Only question is, could they be winding down involuntarily or voluntarily? I'm hoping it's the latter by selling the company :) Nonetheless, valid concerns for a small company when key figures depart.

sidslids

11/05/16 4:16 PM

#37033 RE: dr_lowenstein #35063

maybe this will be brought up at the thing?

bioInvest1

02/28/17 7:20 PM

#38664 RE: dr_lowenstein #35063

Shorts should be afraid. This will easily be $4 a share in a few weeks. Could be as high as $14 per share soon.

nsomniyak

05/23/18 4:34 PM

#44785 RE: dr_lowenstein #35063

Is this two year old info really worth a sticky? Much has changed since April 2016.